[HEADING 1]
Transcription
[HEADING 1]
1 in the region for many years, but current economic situation is expected to change in 2015, which will adversely affect medical device market growth, as less money is made available for healthcare. Additionally, imports may fall as the currency devaluation has made foreign products very expensive. Healthcare sector in Russia The Russian Healthcare market is a market in growth. The lack of efficient tools and equipment with a growing elder burden is a development that Denmark and the Danish system know very well. Here the Danish companies are in the forefront of developing innovative and efficient solutions. However the structure of the market is challenging and the financial situation is adding to the challenge. Even with these challenges there are Danish companies on the market working hard and earning money. In 2013, the Russian medical device market was estimated at USD 6,716.9mn, or USD 47 per capita. This market size is comparable to Canada; in per capita terms, the market is similar to Croatia. The 2008-2013 CAGR was estimated at 0.3%, but the market is expected to contract by a CAGR of 2.9% over the 20132018 period, to USD 5,785.2mn, or USD 41 per capita by 2018. The Russian healthcare system is divided into national, regional, and municipal levels. The national government controls the budget, policy, and registration of technologies, while regional and municipal governments have control over their facilities and budgets. The national government collects taxes and distributes funds to the regional and municipal levels through Mandatory Health Insurance funds. This covers about two-thirds of the cost of procedures. To make up the difference, Russian citizens also have access to voluntary health insurance and private medical care. This system continues to evolve. In 2010, the government implemented the Strategy 2020 initiative to attract investment, create jobs, produce safe and effective products, and reduce the country's dependence on foreign healthcare products to a maximum of 50% by 2020 (Source: http://medtechinsider.com/archives/25933). In January 2013, the government approved a national healthcare development plan for the 2013-2020 period. The programme consists of 11 initiatives that focus on several areas including preventive care, health & wellbeing of mothers & babies, and medical rehabilitation/physiotherapy. The government's national Health project aims to improve healthcare standards. Since the project's implementation, numerous medical facilities have been upgraded. Over 70% of the medical device market is supplied by imports. Russia imported medical devices valued at USD 4,848.9mn in 2013; this represented a fall of 21.8% compared with 2012 and a 2008-2013 CAGR of 1.1%. Imports have grown every year since 2003, with the exception of 2009 and 2013. In the 12 months to September 2014, Russian medical device imports decreased by 26.1%, to USD 4,525.5mn. REHABILITATION EQUIPMENT According to a market research of rehabilitation services conducted by Synopsis medical research centre in 2012, about 12% of the population of Russian Federation suffer from chronic diseases of the musculoskeletal system. The growing number of such patients increase the demand for rehabilitation services. Rehabilitation centres located in Leningrad and Moscow regions (including recently started projects) seem to be more interesting target group. Nowadays both individual and corporate investors are interested in this sector. During the last two years a number of new projects of rehabilitation centres were initiated both in Moscow and Saint Petersburg One can also notice that a range of services is growing and a comprehensive approach to rehabilitation is being implemented. MEDICAL DEVICES The Russian medical device market is expected to contract by a CAGR (compound annual growth rate) of 2.9 % over the 2013-2018 period, due to the weakening of the ruble. Russia was one of the fastest growing markets Most popular rehabilitation equipment: training simulators (cardiovascular‐, bike‐ and bodysimulators for the different groups of muscles and joints) 2 Equipment for water treatment (Charcot’s douche, multifunctional medical baths etc.) walking aids equipment for the massage and manual therapy Rehabilitation equipment may also be acquired by rehabilitation clinics located in resort areas (Krasnodar region, the Caucasus etc.) The introduction of new methods of rehabilitation seems to be not so complicated as introduction of new diagnostic and treatment technologies. Home care rehabilitation equipment is also in demand. most popular devices imported (Source: FINPRO consulting) - to Russia. PHARMA The pharmaceutical industry in Russia has been witnessing strong growth over the last couple of years, with the alimentary/metabolism segment leading the market. The industry grew by 17.5% in 2009 and is expected to reach a value of $10.7 billion by the year 2014. The Russian pharmaceutical market accounts for just 3.6% of the European pharmaceutical industry in terms of value. Both exercise therapy and physiotherapy are very popular methods of medical rehabilitation since the Soviet times. Nearly all public and private clinics are equipped with basic physiotherapy equipment. Both public and private sectors are mainly equipped with Russian made physiotherapeutic technique. Nowadays Russian manufactures produce more than 100 types and 15000 positions of different physiotherapeutic devices. Their lifetime is 10‐15 years, but there are a lot of 20‐25 year old devices still in use. On the one hand, this is an evidence of high quality of domestic production; on the other hand, the time has come to replace those old devices with new and modern ones. International standards for rehabilitation services have changed, patients demands have diversified and increased, and there is a clear demand in Russia for new physiotherapy equipment. However, it is necessary to say that the situation in private healthcare sector is not so crucial and an average lifetime of physiotherapy equipment in use is only 7 years. Besides healthcare institutions, potential clients to buy physiotherapy equipment are nursery schools, private secondary schools and sanatoriums. Russian manufacturers of this equipment are far beyond their western competitors both in design and efficiency of their products, but it is hard to compete with them on price. Thus a foreign supplier of physiotherapy equipment, who is interested in Russian market, should carefully examine the market situation and clearly draw out its competitive advantages in comparison to local competitors. The leading importers of physiotherapy equipment come from the Czech Republic, United Kingdom, Japan and Germany. Orthopaedic devices & prosthesis are among Despite global economic downturn Russian pharmaceutical market remains strong and continues to attract foreign companies. With sales of medicinal products exponentially rising over the last 10 years, both large and midsize Pharma are actively expanding its presence in the Russian market. The forecast for the next 10 years suggest a robust growth of pharmaceutical sales. (www.cromospharma.com) At present time Russian pharmaceutical and medical device market is hugely dependent on outside import. There is a difference of allocation of the state resources, when it comes to medical equipment, which is mostly state funded and pharmaceuticals, mostly a retail market. Medical equipment and pharmaceuticals (public sector accounts for around a quarter of Russia’s pharmaceuticals market) are procured for use in the public sector via electronic tenders, organized in accordance with the recently revised general state procurement legislation. However, in early February 2015 in the framework of the anti-crisis plan and import 3 replacement measures the Russian government restricted state purchases of certain imported medical equipment and goods. Also, the ministry of industry and trade just came up with a proposal to restrict admission to tenders of imported pharmaceuticals, if there are two or more proposals to deliver similar pharmaceuticals from domestic producers. prescription products at 51% and for OTC drugs at 49%. (Source: http://www.dsm.ru/about/news/100/). What can the Trade Council do for You? Trade Council Russia can assist you in finding reliable Russian business partners, locating potential partners, searching for enterprises which meet specific requirements and select the most compatible. Trade Council Russia can be of help by providing all necessary contacts, organize meetings and negotiations with representatives of Russian companies. We offer market visits to Russia and Kazakhstan which might be of interest to newcomers to our markets. The Russian pharmaceutical market ranks second in volume terms after the foodstuff market and is one of the most dynamic and promising specialized markets. The Russian pharmaceutical market ranks among the top ten pharmaceutical markets in the world. In 2011, Russia was 8th in the world. The value of the Russian pharmaceutical market was 28.1 billion USD in end-user prices, which is a 12% increase compared with 2010. (Source: DSM Group). The volume of the market for pharmaceuticals in pharmacy procurement prices decreased by 6,8% in November 2014 in comparison with October 2014 and totalled up to 44,7 bln RUR. The average price of a pharmaceutical package increased for 2,9% and ran at 130,4 RUR in November 2014. From the beginning of 2014 the inflation rate for pharmaceuticals at the pharmacy shops of the country totalled at +8,5% in RUR and -21,1% in US dollars. Svetlana Chernova The market structure of pharmaceuticals did not change radically in November 2014 in comparison with the same period in 2013. The reduction of quantity of pharmaceuticals with the price range of 50-150 RUR per package continued in 2014 (from 20,3% in November 2013 to 17,6% in November 2014), pharmaceuticals of the lowest price segment (i.e. cheaper than 50 RUR per package) saw reduction of the market share from 7,3% to 6,7%. And pharmaceuticals with price tag of 500 RUR per package shared 28,4% of the market in November 2014 which is 2,1% more than in November 2013. Commercial Attaché Head of the Healthcare sector advisory team E-mail [email protected] At the end of November 2014 г. 55% of pharmaceuticals sold were of domestic origin (in physical terms) however due to their low price in comparison with the imported pharmaceuticals in terms of value they show 24% of sales. The commercial segment of the market at the end of November 2014 was presented by 4